Contribution of P1-(A2b subtype) and P2-purinoceptors to the control of vascular tone in the rat isolated mesenteric arterial bed

Br J Pharmacol. 1995 Jun;115(4):648-52. doi: 10.1111/j.1476-5381.1995.tb14981.x.

Abstract

1. The direct vascular effects of adenosine and ATP were compared in the isolated and perfused mesenteric arterial bed of the rat. The actions of analogues of adenosine and ATP were also examined. 2. In preparations at basal tone, adenosine lacked vasoconstrictor actions, while ATP elicited dose-dependent vasoconstrictor responses. When the tone of preparations was raised by adding methoxamine to the perfusate, adenosine and its stable analogue, 2-chloroadenosine (2-CADO) elicited dose-dependent vasodilation. The A2 adenosine receptor agonist, 5'-N-ethylcarboxamidoadenosine (NECA) was active at lower doses than adenosine, while the A2a-selective agonist, CGS 21680 and the selective A1 agonist, N6-cyclopentyladenosine (CPA) failed to induce vasodilatation. ATP and its analogue, 2-methylthio ATP, elicited dose-dependent vasodilatation at doses 400 fold lower than adenosine. 3. Vasodilator responses to adenosine and 2-CADO were sensitive to antagonism by 1 microM 8-sulphophenyltheophylline (8-SPT) and were unaffected by inhibition of nitric oxide synthase by N omega-nitro-L-arginine methyl ester (L-NAME). In contrast, vasodilator responses to ATP were not sensitive to antagonism by 8-SPT and were almost abolished by L-NAME treatment. 4. These results indicate that in the rat mesenteric arterial bed, while both adenosine and ATP participate in the purinergic control of vascular tone, adenosine appears to be a weaker vasodilator than ATP and lacks vasoconstrictor action. A2b adenosine receptors account for the adenosine-induced vasodilatation which is independent of the production of nitric oxide.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Chloroadenosine / pharmacology
  • Adenosine / analogs & derivatives
  • Adenosine / pharmacology*
  • Adenosine Triphosphate / analogs & derivatives
  • Adenosine Triphosphate / pharmacology*
  • Adenosine-5'-(N-ethylcarboxamide)
  • Animals
  • Antihypertensive Agents / pharmacology
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • In Vitro Techniques
  • Male
  • Mesenteric Arteries / drug effects*
  • Mesenteric Arteries / metabolism
  • Methoxamine / pharmacology
  • NG-Nitroarginine Methyl Ester
  • Phenethylamines / pharmacology
  • Rats
  • Rats, Wistar
  • Receptors, Purinergic P1 / drug effects
  • Receptors, Purinergic P1 / metabolism*
  • Receptors, Purinergic P2 / drug effects
  • Receptors, Purinergic P2 / metabolism*
  • Theophylline / analogs & derivatives
  • Theophylline / pharmacology
  • Thionucleotides / pharmacology
  • Vasoconstriction / drug effects
  • Vasoconstrictor Agents / pharmacology
  • Vasodilator Agents / pharmacology

Substances

  • Antihypertensive Agents
  • Enzyme Inhibitors
  • Phenethylamines
  • Receptors, Purinergic P1
  • Receptors, Purinergic P2
  • Thionucleotides
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine
  • 2-Chloroadenosine
  • Adenosine-5'-(N-ethylcarboxamide)
  • N(6)-cyclopentyladenosine
  • 8-(4-sulfophenyl)theophylline
  • Adenosine Triphosphate
  • Arginine
  • Theophylline
  • Methoxamine
  • Adenosine
  • NG-Nitroarginine Methyl Ester
  • 2-methylthio-ATP